Replies to post #47968 on 22nd Century Group Inc (XXII)

[brooklyn13]

History will not look kindly on Dr Gottlieb's tenure at the FDA. Both stronger opioids and nicotine delivery systems have flooded the market on his watch with zero regulatory pushback. Lots of talk, though.

Meanwhile, XXII has the patents. But it also has a mediocre management team and, as a result, is a lousy stock to own. Patience has not been its own reward around here.

We'll see how smirky Henry remains in the upcoming conference call.

[nonameface13]

So in other words, we're still on track for something big happening in March, as predicted.

Can't say I like this drop.

Clearly, the science is still there.

It is also true... a man would only want to leave his legacy in the hands of someone who will see it through. The panic is premature.

I can say from experience, the pull to be a family man can temper career ambitions. Scott is a cancer survivor. He has a sense of how precious time is. Let's see what he does... the 'why' does matter, don't get me wrong... but let's see who replaces him.

Let's hear from XXII in the coming days, and the FDA in the coming (few) weeks.